Methotrexate-related nonnecrotizing multifocal axonopathy detected by beta-amyloid precursor protein immunohistochemistry

Arch Pathol Lab Med. 2002 Jan;126(1):79-81. doi: 10.5858/2002-126-0079-MRNMAD.

Abstract

We describe a 64-year-old woman with biphenotypic leukemia involving the meninges who received 2 doses of intrathecal methotrexate. Soon after treatment, the patient developed postural rigidity and a marked decline in mental status. The patient died of respiratory failure 1 month after methotrexate treatment was initiated. At autopsy, the brain was grossly normal. Routine microscopy showed no evidence of leukemic infiltrates or necrotizing lesions. However, when stained with beta-amyloid precursor protein, multifocal axonal injury was evident in the brain, spinal cord, and nerve roots. Our findings show that immunohistochemical staining for beta-amyloid precursor protein can effectively demonstrate axonal injury associated with methotrexate neurotoxicity, even when conventional staining procedures are negative. This technique may therefore reveal a possible pathologic substrate for some of the neurological complications seen in patients with methotrexate neurotoxicity.

Publication types

  • Case Reports

MeSH terms

  • Amyloid beta-Protein Precursor / metabolism*
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects*
  • Axons
  • Central Nervous System Diseases / chemically induced*
  • Central Nervous System Diseases / metabolism
  • Central Nervous System Diseases / pathology*
  • Female
  • Humans
  • Immunohistochemistry
  • Injections, Spinal
  • Leukemia / drug therapy
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects*
  • Middle Aged

Substances

  • Amyloid beta-Protein Precursor
  • Antimetabolites, Antineoplastic
  • Methotrexate